Pharma-Bio Serv, Inc.
PBSV
$0.59
$0.024.07%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 87.08% | 89.97% | -3,403.70% | -181.29% | -159.35% |
| Total Depreciation and Amortization | 26.43% | 20.49% | 10.41% | -1.01% | -6.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.74% | 69.20% | 70.57% | 61.05% | 27.89% |
| Change in Net Operating Assets | -249.61% | -161.45% | -185.15% | -193.09% | -65.53% |
| Cash from Operations | 62.08% | -23.61% | -202.53% | -198.91% | -129.97% |
| Capital Expenditure | 95.80% | -14,745.45% | -20,500.00% | -- | -2,087.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.53% | -104.74% | 143.86% | 684.94% | 71.48% |
| Cash from Investing | -7.75% | -107.56% | 139.86% | 664.52% | 67.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -180.36% | -85.00% | -22.73% | 90.38% | 67.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.13% | 0.13% | 0.13% | 0.09% | 0.09% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.03% | -0.46% | -0.07% | 2.21% | 1.40% |
| Foreign Exchange rate Adjustments | 351.41% | 146.51% | 132.85% | -409.38% | -125.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.90% | -170.19% | 69.13% | 210.10% | 8.42% |